JB Pharma Q1 Results: Net profit surges 35% YoY to Rs 142 crore
Domestic business revenue grew 17% YoY to Rs 489 crores in Q1FY24, despite sales for the acute business being impacted due to the delayed monsoons.The company said all its four acquisitions – the probiotic portfolio, Paedia brands, Azmarda and Razel have performed well
